Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently

Documenti analoghi

• Clinical and Angiographic Outcomes after Intracoronary Bare-Metal Stenting
  di: Hsieh, I-Chang, et al.
  Pubblicazione: (2014)
• Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting
  di: Tsai, Ming-Lung, et al.
  Pubblicazione: (2020)
• Vessel Size and Long-Term Outcomes After Limus-Based Drug-Eluting Stent Implantation Focusing on Medium- and Small-Diameter Vessels
  di: Hsieh, I-Chang, et al.
  Pubblicazione: (2016)
• Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation.
  di: I-Chang Hsieh, et al.
  Pubblicazione: (2015-01-01)
• Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation
  di: Hsieh, I-Chang, et al.
  Pubblicazione: (2015)